Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!
RUEN
Разместить новость

The FDA today announced clearance of a new screening test that predicts a patient’s risk for future CHD events

16.12.20141781
The agency has cleared the test for use in all adults with no history of CHD.

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

15.12.20141994
Patients undergoing catheter ablation for atrial fibrillation (AF) often experience recurrent arrhythmias within the first few months post-ablation.

Stroke and Major Bleeding Risk in Elderly Patients Aged ?75 Years With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

12.12.20141936
What are the risks of stroke and bleeding in elderly patients with atrial fibrillation (AF) associated with oral anticoagulation?

Opportunities for treatment optimization with beta-blockers, ivabradine often missed in HF clinic

11.12.20141739
Most HF patients with reduced ejection fraction treated at a community HF clinic received beta-blocker therapy to maintain a heart rate <70 bpm, but relatively few require beta-blocker up-titration or ivabradine initiation, results of a new study suggest.

Recent Cox-2 inhibitor use increased ischemic stroke mortality risk

10.12.20141596
The use of cyclooxygenase-2 inhibitors before hospitalization for stroke is associated with increased mortality in cases of ischemic stroke, but not hemorrhagic stroke, according to recent findings.

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

08.12.20141711
Experimental data indicate that reducing factor XI levels attenuates thrombosis without causing bleeding, but the role of factor XI in the prevention of postoperative venous thrombosis in humans is unknown. FXI-ASO (ISIS 416858) is a second-generation antisense oligonucleotide that specifically reduces factor XI levels.

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study

05.12.20141775
Does aggressive risk factor management (RFM) improve outcomes after catheter ablation of atrial fibrillation (AF)?
123...226227228229230...363364365
Enter the Society
Subscribe to Newsletter
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.